The evolutionary history of 2,658 cancers
European Bioinformatics Institute · Wellcome Sanger Institute · +375 more institutions
Abstract
Abstract Cancer develops through a process of somatic evolution 1,2 . Sequencing data from a single biopsy represent a snapshot of this process that can reveal the timing of specific genomic aberrations and the changing influence of mutational processes 3 . Here, by whole-genome sequencing analysis of 2,658 cancers as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) 4 , we reconstruct the life history and evolution of mutational processes and driver mutation sequences of 38 types of cancer. Early oncogenesis is characterized by mutations in a constrained set of driver genes, and specific copy number…
Citation impact
- FWCI
- 63.99
- Percentile
- 100%
- References
- 50
Authors
1441- MGMoritz Gerstung
European Bioinformatics Institute, Wellcome Sanger Institute, Bioinformatics Institute, European Molecular Biology Laboratory
- CJClemency Jolly
The Francis Crick Institute
- ILIgnaty Leshchiner
Broad Institute
- SCStefan C. Dentro
The Francis Crick Institute, Wellcome Sanger Institute, Open Data Institute, University of Oxford
- SGSantiago Gonzalez
European Bioinformatics Institute
Topics & keywords
- Evolutionary biology
- Biology
- Partnerships for the goals
Funding
- LKLi Ka Shing Foundation
- WTWellcome TrustAward: FC001202
- FCFrancis Crick InstituteAward: FC001202
- CRCancer Research UKAwards: A17197, C14303, C14303/A17197, FC001202, C14303/A17197 and A19274, A19274
- UOUniversity of Cambridge
- ECEuropean CommissionAwards: 703594, 747852
- FWFonds Wetenschappelijk Onderzoek
- HWHutchison Whampoa Limited
- NINational Institutes of HealthAwards: R01 CA132897, CA016672, P30 CA016672, NIH R01
- NSNatural Sciences and Engineering Research Council of Canada
- MRMedical Research CouncilAwards: FC001202, MR/L016311/1, MR/L016311/1
- NINational Institute of Mental Health
- NCNational Cancer InstituteAwards: P30 CA016672, CA016672, R01 CA132897, NIH R01 CA132897